Current Report Filing (8-k)
July 21 2021 - 6:06AM
Edgar (US Regulatory)
0001579823
false
0001579823
2021-07-19
2021-07-19
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): July 19, 2021
|
NewAge,
Inc.
|
|
|
(Exact
name of registrant as specified in its charter)
|
|
Delaware
|
|
001-38014
|
|
27-2432263
|
(State
or other jurisdiction
|
|
(Commission
|
|
(I.R.S.
Employer
|
of
incorporation)
|
|
File
Number)
|
|
Identification
Number)
|
2420
17th Street, Suite
220, Denver,
CO
80202
|
(Address
of principal executive offices) (Zip Code)
|
(303)
566-3030
|
(Registrant’s telephone number, including area code)
|
|
(Former name or former address, if changed since last report)
|
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
|
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
Common
Stock, par value $0.001 per share
|
|
NBEV
|
|
Nasdaq
Capital Market
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
Growth Company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
5.02
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
On
July 19, 2021 (the “Effective Date”), NewAge, Inc. (the “Company”) appointed Kevin Manion as Chief Financial
Officer of the Company.
Most
recently, Mr. Manion served as Chief Financial Officer of Calavo Growers, Inc. (Nasdaq: CVGW), an international consumer goods and farm
products company, from May 2020 to July 2021. Previously, Mr. Manion held financial leadership positions with companies including Century
Snacks, Young’s Market Company, Bolthouse Farms, Hostess Brands, Nestle USA and Kraft General Foods. Mr. Manion served as Chief
Financial Officer of the Centre for Neuro Skills, a provider of state-of-the-art brain injury rehabilitation services, from January 2019
to April 2020; Chief Financial Officer-Operations of Green Dot Corporation (NYSE: GDOT), a financial technology and bank holding company,
from October 2016 to January 2019; and Chief Financial Officer of New Century Snacks/Snak Club, a privately-held food products company,
from March 2015 to October 2016. Mr. Manion began his career in public accounting at Arthur Andersen & Co.
There
is no arrangement or understanding between Mr. Manion and any other person pursuant to which Mr. Manion was selected as the Company’s
Chief Financial Officer. Mr. Manion has no family relationships with any director or executive officer of the Company. In addition, Mr.
Manion has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation
S-K.
On
July 19, 2021, Mr. Manion and the Company entered into an Employment Agreement (the “Agreement”), under which Mr. Manion’s
employment will be for a term commencing on July 19, 2021 and ending on January 1, 2024 and may be automatically renewed for one-year
periods thereafter. Under the terms of the Agreement, Mr. Manion will receive an annual base salary of $550,000, and will be eligible
to receive an annual performance-based cash bonus with a target bonus opportunity equal to 0.8 times his annual base salary with potential
to receive 1.6 times his annual base salary, based upon the attainment of certain performance metrics established by the Company’s
board of directors (the “Board”). Mr. Manion will receive a minimum guaranteed performance bonus of no less than $440,000
for 2021. His actual performance bonus for 2021 will be the greater of $440,000 and the award amount determined based on the performance
target and metrics and will not be pro-rated. Mr. Manion will be eligible to participate in the Company’s long-term incentive plan
(“LTIP”); provided that, annual equity grants under the LTIP will be in restricted stock units (“RSUs”) and performance
stock units (“PSUs”) vesting over a three-year period from the grant date having an initial value on the grant date of not
less than 0.8 times Mr. Manion’s annual base salary and with the potential to pay out on vesting at up to three times the number
of RSUs and PSUs subject to the award, based on achievement of the targets and metrics established by the Board.
As
a sign-on bonus, on the Effective Date, Mr. Manion will receive $200,000 in cash and an award of the Company’s restricted stock
(the “Stock Award”) having a value of $400,000 that will vest in two installments of 50% each on each of the first two anniversaries
of the Effective Date. If Mr. Manion’s employment is terminated by him without Good Reason (as defined in the Agreement) or by
the Company for Cause (as defined in the Agreement) (i) prior to the first anniversary of the Effective Date, the entire Stock Award
will be forfeited, and (ii) after the first anniversary of the Effective Date and prior to the second anniversary of the Effective Date,
50% of the Stock Award will be forfeited.
The
foregoing description of the terms of the Agreement is not complete and is subject to and qualified by the terms of the Agreement. A
copy of the Agreement is attached hereto as Exhibit 10.1 and is incorporated herein by reference.
Item
7.01
|
Regulation
FD Disclosure.
|
Attached
hereto as Exhibit 99.1 is a press release issued by the Company on July 21, 2021 announcing the appointment of Mr. Manion as Chief Financial
Officer of the Company.
The
information under Item 7.01 (including Exhibit 99.1) is furnished pursuant to Item 7.01 and shall not be deemed filed for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference into any
filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference
in such filing.
Item
9.01
|
Financial
Statements and Exhibits.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
NewAge, Inc.
|
|
|
|
Date:
July 21, 2021
|
By:
|
/s/
Brent D. Willis
|
|
|
Brent
D. Willis
Chief
Executive Officer
|
NewAge (NASDAQ:NBEV)
Historical Stock Chart
From Aug 2024 to Sep 2024
NewAge (NASDAQ:NBEV)
Historical Stock Chart
From Sep 2023 to Sep 2024